Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : EMC How high can it go? -- Ignore unavailable to you. Want to Upgrade?

To: Gus who wrote (10560)	7/6/2000 11:34:28 AM
From: Gus	Read Replies (1) \| Respond to of 17183

So what's in a name? MR is a director of the new Perkin-Elmer (PKI), which used to be the former EG&G Corporation (EGG) until September 1999 when it closed its May 1999 acquisition of the Analytical Instruments Division of the original Perkin-Elmer Corporation (PKN) and the rights to the Perkin-Elmer trademark. By then the original Perkin-Elmer had already reorganized itself as the PECorporation focused exclusively on life sciences with two operating businesses - PE Biosystems (PEB) and Celera Genomics (CRA). The PECorporation and PE Biosystems were recapitalized and merged last 2/2000 as PEB so PEB is now the parent company of CRA. Interestingly, PKI is a Massachusetts company with $1.7b in revenues derived from four lines of businesses: Fluid Sciences, Instruments, Optoelectronics and Life Sciences.